Teleflex, Inc. (TFX)

INDUSTRIALS: CONGLOMERATES
SIC: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

550 E SWEDESFORD RD WAYNE, PA 19087

Teleflex Inc. Operates a diversified industrial company specializing in the design, manufacture and distribution of specialty-engineered products, serving a range of customers in niche segments of the commercial, medical and aerospace industries.

Data as of 2020-10-17
Market Cap16.909 Billion Shares Outstanding46.516 Million Avg 30-day Volume250.919 Thousand
P/E Ratio35.6 Dividend Yield0.374 EPS10.16
Price/Sales9.001 Price cash flow ratio41.3 Price free cash flow ratio-216.8
Book Value66.59 Price to Tangible Book-11.17 Alpha0.01
Short Interest Ratio2.756 % Short Interest to Float1.6 R-squared0.368642
BETA1.02966 52-week High/Low409.27 / 221.27 Stddev0.072831
View SEC Filings from TFX instead.
Q2 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 5 7 -28.57% 2 (0.13%) 2 (0.13%) 0.0%
Funds Holding: 520 503 3.38% 101 (6.59%) 104 (6.65%) -2.88%
13F shares: 42.473 Million 42.369 Million 0.24% 8.85 Million 9.111 Million -2.86%
% Ownership 91.3086 91.3711 -0.07% 19.0257 19.6481 -3.17%
New Positions: 65 59 10.17% 13 19 -31.58%
Increased Positions 164 166 -1.2% 28 34 -17.65%
Closed Positions 43 78 -44.87% 15 17 -11.76%
Reduced Positions 205 190 7.89% 46 38 21.05%
Total Calls 87.914 Thousand 60.321 Thousand 45.74% 9.8 Thousand 10 Thousand -2.0%
Total Puts 29.6 Thousand 30.001 Thousand -1.34% 6.6 Thousand 3 Thousand 120.0%
PUT/CALL Ratio 0.34 0.5 -32.0% 0.67 0.3 123.33%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding TFX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding TFX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

400 total shares from 2 transactions

Exercise Derivative Conversion (M)

400 total shares from 2 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

KLASKO STEPHEN K. M.D.

  • Director
1,121 2020-09-25 13

DEREN JOHN VP & CHIEF ACCOUNTING OFFICER

  • Officer
952 2020-05-09 4

HICKS CAMERON P CORP. VP, HR & COMMUNICATIONS

  • Officer
8,193 2020-05-07 5

BABICH GEORGE JR

  • Director
11,031 2020-05-05 1

RANDLE STUART A

  • Director
2,898 2020-05-05 1

DUNCAN CANDACE H

  • Director
2,787 2020-05-05 1

HAGGERTY GRETCHEN R

  • Director
2,879 2020-05-05 1

PACKER RICHARD A

  • Director
2,713 2020-05-05 1

KRAKAUER ANDREW A

  • Director
2,232 2020-05-05 1

HEINMILLER JOHN C

  • Director
2,114 2020-05-05 1

POWELL THOMAS E EXECUTIVE VICE PRESIDENT & CFO

  • Officer
11,382 2020-02-28 5

KELLY LIAM PRESIDENT & CEO

  • Officer
  • Director
23,355 2020-02-28 2

LEYDEN JAMES J VP, GENERAL COUNSEL, SECRETARY

  • Officer
16,960 2020-02-28 3

WIJKER MARIO VICE PRESIDENT, QARA

  • Officer
582 2020-02-25 2

WINTERS JAMES VICE PRESIDENT, MFG AND SUPPLY

  • Officer
963 2020-02-25 2

SMITH BENSON

  • Director
47,861 2020-02-18 3

BOYLAN KAREN VP, GLOBAL STRATEGIC PROJECTS

  • Officer
2,258 2019-06-20 0

KENNEDY THOMAS ANTHONY SENIOR VP, GLOBAL OPERATIONS

  • Officer
2,863 2018-09-19 0

FOSTER W KIM

  • Director
3,580 2018-05-16 0

GRAVES JEFFREY A

  • Director
8,462 2017-05-09 0

BARRON PATRICIA C

  • Director
10,693 2017-02-23 0

COOK WILLIAM ROLAND

  • Director
20,195 2016-08-12 0

LUBSEN SIGISMUNDUS W W

  • Director
13,905 2015-03-16 0

YOH HAROLD L III

  • Director
10,277 2015-03-16 0

ZUG JAMES W

  • Director
10,694 2014-04-17 0

MILLER LAURENCE G EVP, CHF ADMIN OFF, GC & SEC'Y

  • Officer
43,928 2013-03-18 0

MEIER RICHARD A EXEC. VICE PRES. AND CFO

  • Officer
33,590 2012-02-28 0

NORTHFIELD VINCENT EXEC. VP - GLOBAL OPS-MEDICAL

  • Officer
No longer subject to file 2011-03-08 0

WILLIAMS CHARLES EDWARD CORP. CONTROLLER AND CAO

  • Officer
5,950 2011-03-04 0

SUDDARTH JOHN B PRES-AEROSPACE, COMM & MED OEM

  • Officer
17,460 2011-03-01 0

BLACK JEFFREY P CHAIRMAN, PRESIDENT, CEO

  • Officer
  • Director
No longer subject to file 2010-12-31 0

WAASER R ERNEST PRESIDENT - MEDICAL

  • Officer
20,518 2010-03-01 0

GORDON KEVIN K EXEC. VICE PRES. & CFO

  • Officer
No longer subject to file 2009-12-31 0

GABORIAULT RANDALL P SR. VICE PRES. & CHF INFO OFF

  • Officer
No longer subject to file 2009-12-31 0

VON SELDENECK JUDITH M

  • Director
1,908 2008-11-21 0

MCDOWELL JULIE SR. VP CORP. COMMUNIC.

  • Officer
430 2008-02-26 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

KLASKO STEPHEN K. M.D. - Director

2020-09-28 21:27:51 -0400 2020-09-25 M 200 d 200 direct yes

KLASKO STEPHEN K. M.D. - Director

2020-09-28 21:27:51 -0400 2020-09-25 S 200 $326.15 d 1,121 direct yes 1.4544 0.2474 1.4544 2 0.0 1

KLASKO STEPHEN K. M.D. - Director

2020-09-28 21:27:51 -0400 2020-09-25 M 200 $58.25 a 1,321 direct yes 1.4544 0.2474 1.4544 2 0.0 1

KLASKO STEPHEN K. M.D. - Director

2020-08-26 16:41:15 -0400 2020-08-25 M 200 $58.25 a 1,321 direct yes 1.2465 4.2863 -4.4099 7.3367 5 -14.0896 17

KLASKO STEPHEN K. M.D. - Director

2020-08-26 16:41:15 -0400 2020-08-25 M 200 d 400 direct yes

KLASKO STEPHEN K. M.D. - Director

2020-08-26 16:41:15 -0400 2020-08-25 S 200 $373.74 d 1,121 direct yes 1.2465 4.2863 -4.4099 7.3367 5 -14.0896 17

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments